Skip to main content
. 2016 Feb 12;30(5):673–679. doi: 10.1038/eye.2016.13

Table 1. Characteristics of diabetic patients and controls.

  Diabetic patients (n=150)
Controls (n=50) P-value
  Overall patients no-DR group (n=131) mild-NPDR group (n=19)    
Age (years) 60.9±8.3 60.6±8.3 62.7±8.4 60.0±8.4 0.158a
Gender, n (%)         0.540b
 Male 94 (62.7) 80 (61.1) 14 (73.7) 30 (60.0)  
 Female 56 (37.3) 51 (38.9) 5 (26.3) 20 (40.0)  
           
Duration of diabetes (years) 7.1±6.6 6.4±5.6 12.8±10.4   <0.001c
BCVA 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0  
HbA1c (%) 7.4±1.3 7.4±1.2 8.0±1.3   0.050c
IOP (mmHg) 14.4±2.5 14.5±2.5 14.1±2.8 14.3±2.2 0.758a
Refractive error 0.24±1.47 0.28±1.53 -0.02±1.03 0.05±1.23 0.466a
Treatment, n (%)         <0.001b
 Diet 14 (9.3) 12 (9.2) 2 (10.5)    
 OHA 116 (77.3) 106 (80.9) 10 (52.6)    
 Insulin 13 (8.7) 11 (8.4) 2 (10.6)    
 INS+OHA 7 (4.7) 2 (1.5) 5 (26.3)    

Abbreviations: BCVA, best-corrected visual acuity (logMAR (logarithm of the minimum angle of resolution)); HbA1c, glycated hemoglobin; INS, Insulin; IOP, intraocular pressure; mild-NPDR group, diabetes patients with signs of mild nonproliferative diabetic retinopathy (NPDR); n, number of patients; no-DR group, diabetes patients without any sign of diabetic retinopathy (DR); OHA, oral hypoglycaemic agent.

a

One-way ANOVA test.

b

χ2-test.

c

Student's t-test for unpaired data no-DR group vs mild-NPDR group. Statistical significant P-values are written in bold.